Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 3,075 shares at $3.99 ($12K) on 2020-05-05, disclosed to the SEC on 2020-06-12.
Scheduled purchase ($12k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.03 | 75 | $302 | 2.6% |
| 2 | $4.05 | 150 | $608 | 5.2% |
| 3 | $4.04 | 150 | $606 | 5.2% |
| 4 | $4.03 | 150 | $605 | 5.2% |
| 5 | $4.03 | 150 | $605 | 5.2% |
| 6 | $4.02 | 150 |
| $603 |
| 5.2% |
| 7 | $4.01 | 150 | $602 | 5.1% |
| 8 | $4.01 | 150 | $602 | 5.1% |
| 9 | $3.99 | 150 | $599 | 5.1% |
| 10 | $3.97 | 150 | $596 | 5.1% |
| 11 | $4.02 | 150 | $603 | 5.2% |
| 12 | $3.93 | 150 | $590 | 5.0% |
| 13 | $3.81 | 75 | $286 | 2.4% |
| 14 | $3.76 | 75 | $282 | 2.4% |
| 15 | $3.82 | 75 | $287 | 2.4% |
| 16 | $3.78 | 75 | $284 | 2.4% |
| 17 | $3.77 | 75 | $283 | 2.4% |
| 18 | $3.68 | 75 | $276 | 2.4% |
| 19 | $3.61 | 75 | $271 | 2.3% |
| 20 | $3.59 | 75 | $269 | 2.3% |
| 21 | $3.49 | 75 | $262 | 2.2% |
| 22 | $3.34 | 75 | $251 | 2.1% |
| 23 | $3.35 | 75 | $251 | 2.1% |
| 24 | $3.45 | 75 | $259 | 2.2% |
| 25 | $3.35 | 75 | $251 | 2.1% |
| 26 | $3.29 | 75 | $247 | 2.1% |
| 27 | $3.31 | 75 | $248 | 2.1% |
| 28 | $3.44 | 75 | $258 | 2.2% |
| 29 | $3.54 | 75 | $266 | 2.3% |
| 30 | $3.48 | 75 | $261 | 2.2% |
| Total | $3.81 avg | 3,075 | $12K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |